WP-5 on
Cancer registry indicators
WP-5 is led by Renée Otter (Comprehensive
Cancer Centre Northern-Netherland - IKN).
WP-5 has a double aim: to continue the Cancer Registry
(CR) promotion in countries without CRs (i.e. Greece and Luxembourg)
and to identify, through qualitative questionnaires and forum discussion
amongst European CRs, where adequate data for the production of
cancer indicators is lacking, which kind of data is lacking, and
which are major problems reported by the CRs.
Cancer Registry qualitative questionnaire
This work package aims to improve population-based cancer registration
of cancer indicators, in particular “stage at diagnosis”
(extension of tumour at diagnosis), “cancer treatment delay”
and “compliance with cancer guidelines”. To promote
the collection of these indicators it is necessary to get insight
in the present situation in all European cancer registries. WP-5
addressed the following questions:
- Which European cancer registries routinely collect data items
for these cancer indicators
- Which European cancer registries do not collect data items
for these cancer indicators and what are the reasons for not collecting
these items (lack of budget, staff, data sources, legislation)
- What is the contribution of European cancer registries to the
description of cancer burden or evaluation of cancer control.
To answer the above mentioned questions a specific
for this purpose developed questionnaire will be addressed to all
European cancer registries (see the protocol).
The questionnaire
is distributed to the European Cancer Registries. A pilot of the
questionnaire has been conducted with 10 Cancer Registries and the
ENCR Steering Committee. The questionnaire asks about contact details
of the registry (to make it possible to clearify some answers if
necessary), registry description, conditions of cancer registration,
funding of cancer registration, data sources, registration criteria,
screening, diagnosis, coding topography and morphology, tumour items
(i.e. stage at diagnosis), treatment items (i.e. date of diagnosis),
follow-up items, role in guideline evaluation and registry output.
Finally we ask the CR for permission to share the data with the
public or only with ENCR members. Update of the survey was presented
at IACR 2010 in Japan).
The questionnaire is developed for the EUROCHIP-3
project. To prevent duplication of effort, the content of the questionnaire
has been discussed with other parties like the ENCR (European Network
of Cancer Registries) and the EUROCOURSE project . To reduce the
workload for the CR some questions already asked for other projects
(ENCR CI5 questions) will be filled out by default. The updated
answers will also be shared with the ENCR. The EUROCOURSE project
expressed interest in some questions.
Greece and Luxembourg
WP-5 assisted the two EU countries without a Cancer Registry in
developing one. WP-5 helped Ministries of Health in Luxembourg and
Greece with scientific support in the development of a quality and
sustainable CR in line with EU recommendations. Scientific Meetings,
Ministerial Meetings, Training course (for Greece CR) and supporting
networks were organised throughout the project. Since February 2012,
the two countries seem to have a functioning Cancer Registry.
Final material
| Cancer Registry qualitative questionnaire
- Report |
|
| Cancer Registry promotion in Greece |
|
| Cancer Registry promotion in Luxembourg |
|
Meetings
| Domain |
Date |
Place |
Report |
| Luxembourg Cancer registry discussion |
05-05-2011 |
Luxembourg (LUX) |
|
| Luxembourg Cancer registry discussion |
21-02-2011 |
Amsterdam (NL) |
|
| WP-5 questionnaire discussion |
08-06-2010 |
Phone meeting |
- |
| WP-5 questionnaire discussion |
05-11-09 |
Amsterdam (NL) |
- |
| Training course for Greek cancer registry operators |
21/25-09-09 |
Groningen (NL) |
|
| WP-5 questionnaire discussion |
25-08-09 |
Eindhoven (NL) |
- |
| WP-5 questionnaire discussion |
08-04-09 |
Amsterdam (NL) |
- |
| WP-5 activity discussion |
10-03-09 |
Amsterdam (NL) |
- |
| WP-5 questionnaire discussion |
27-02-09 |
Lyon (F) |
- |
Original Material
| Cancer Registry qualitative questionnaire
- Protocol |
|
| Cancer Registry qualitative questionnaire - Questionnaire |
|
|